Alcon Launches Systane Hydration Multi-Dose Preservative-Free Lubricant Eye Drops in the U.S.
April 28 2021 - 9:30AM
Business Wire
- Innovative HydroBoost Technology offers long-lasting relief
for patients with sensitive eyes or who use dry eye drops more than
four times per day
- Latest formulation joins the fast-growing preservative-free
segment of artificial tears
- Systane Hydration Multi-Dose Preservative-Free (MDPF) is
enabled by patented PureFlow bottle technology
Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated
to helping people see brilliantly, today announced the U.S. launch
of the newest addition to its innovative portfolio of dry eye
products – Systane® Hydration Multi-Dose Preservative-Free (MDPF)
Lubricant Eye Drops. With its proprietary HydroBoost® Technology,
this new preservative-free eye drop provides extra moisture for
patients with sensitive dry eyes.
Systane Hydration MDPF joins the fast-growing preservative-free
segment of artificial tears, which represents over 40% of the
global market.1 Systane is the leading artificial tear brand
globally2; however, up to now, it has not been available in a
convenient, multi-dose preservative-free formulation.
Dry eye patients who use drops frequently and patients following
surgery often respond best to preservative-free artificial tears to
help relieve their symptoms, restore ocular surface3 and provide
long-lasting relief,” said Eric D. Donnenfeld, M.D., FAAO,*
Ophthalmic Consultants of Long Island, NY.
Systane Hydration MDPF is a new option for patients who are
suffering from aqueous deficient dry eye and is used as a
protectant against further irritation and to relieve dryness of the
eye. In an in vitro study, Systane Hydration with HydroBoost’s
dual-polymer technology (sodium hyaluronate and HP-Guar) provided
2X greater cell hydration and protection versus a formulation with
sodium hyaluronate alone.3 This offers patients a unique
combination that helps retain the lubricants for lasting dry eye
symptom relief without the use of preservatives.
“I am excited to share Systane Hydration MDPF Lubricant Eye
Drops with my dry eye patients who use drops frequently throughout
the day to help relieve their symptoms and provide long-lasting
relief,” said Paul Karpecki, O.D., FAAO,* Kentucky Eye
Institute.
“We are expanding our over-the-counter portfolio of the #1
doctor recommended artificial tear brand, Systane, to meet the
growing demand for dry eye solutions in the U.S. especially for
patients using drops more than four times per day,” said Sergio
Duplan, President, North America at Alcon. “Since launching Systane
Hydration Preservative-Free in single-use vials last year, we have
captured the confidence of dry eye sufferers who voted the drop
Product of the Year in a Kantar survey of 40,000 consumers.4 We are
excited to continue bringing innovations like Systane Hydration
MDPF to the market to provide them long-lasting relief.”
Systane Hydration MDPF Lubricant Eye Drops will be available in
the U.S. at all major pharmacies and online retailers. Around the
world, Systane Hydration PF, along with Systane Ultra PF, are now
available in multi-dose preservative-free formulas in 13 countries
with more launches planned throughout the year.
Important Information for the Systane
Family of Products
Systane lubricant eye drops have been clinically proven to
reduce the symptoms of dry eye, providing fast, long-lasting relief
and comfort. Systane is the best-selling brand of artificial tears
and the #1 global consumer brand.2 Systane Complete provides
symptom relief for people who suffer from evaporative dry eye,
aqueous tear-deficient dry eye or mixed dry eye. While Systane
Ultra is designed for dry eye with aqueous deficient patients,
Systane Balance lubricant eye drops are designed specifically for
patients with dry eye associated with Meibomian Gland
Dysfunction.
ABOUT ALCON
Alcon helps people see brilliantly. As the global leader in eye
care with a heritage spanning more than seven decades, we offer the
broadest portfolio of products to enhance sight and improve
people’s lives. Our Surgical and Vision Care products touch the
lives of more than 260 million people in over 140 countries each
year living with conditions like cataracts, glaucoma, retinal
diseases and refractive errors. Our more than 23,000 associates are
enhancing the quality of life through innovative products,
partnerships with eye care professionals and programs that advance
access to quality eye care. Learn more at www.alcon.com.
References
- Alcon internal Estimates based on third party data.
- Based on internal calculations by Alcon using third-party data;
Alcon date on file, 2019.
- Rangarajan R, Kraybill B, Ogundele A, Ketelson H. Effects of a
Hyaluronic Acid/Hydroxypropyl Guar Artificial Tear Solution on
Protection, Recovery, and Lubricity in Models of Corneal
Epithelium. J Ocul Pharmacol Ther. 2015;31(8):491-497.
- 2021 Product of the Year Winner - Eye Care Category. Survey of
40,000 people by Kantar.
*Eric D. Donnenfeld, M.D., FAAO and Paul Karpecki, O.D., FAAO
are paid Alcon consultants
Connect with us on Facebook LinkedIn
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210428005680/en/
Investor Relations Christina
Cheng + 41 589 112 110 (Geneva) + 1 817 615 2789 (Fort Worth)
investor.relations@alcon.com
Media Relations Steven Smith
+ 41 589 112 111 (Geneva) + 1 817 551 8057 (Fort Worth)
globalmedia.relations@alcon.com
Alcon (NYSE:ALC)
Historical Stock Chart
From Jun 2024 to Jul 2024
Alcon (NYSE:ALC)
Historical Stock Chart
From Jul 2023 to Jul 2024